Submitted by Anonymous (not verified) on 18 June 2025 - 16:10
Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 45, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 45, Status: Authorised